Novel clinical, molecular and bioinformatics insights into the genetic background of autism

Abstract Background Clinical classification of autistic patients based on current WHO criteria provides a valuable but simplified depiction of the true nature of the disorder. Our goal is to determine the biology of the disorder and the ASD-associated genes that lead to differences in the severity a...

Full description

Saved in:

Bibliographic Details
Published in:	Human genomics 2022-09, Vol.16 (1), p.1-39, Article 39
Main Authors:	Talli, Ioanna, Dovrolis, Nikolas, Oulas, Anastasis, Stavrakaki, Stavroula, Makedou, Kali, Spyrou, George M., Maroulakou, Ioanna
Format:	Article
Language:	eng
Subjects:	ASD Autism Behavior Bioinformatics Classification Clinical phenotype Cognition & reasoning Cognitive ability Datasets Disease Genes Genetic diversity Genetic variation Genomes Genomics Genotype & phenotype Genotypes Health risk assessment Intellectual disabilities Intelligence Language Linguistics Memory Patients Phenotypes Precision medicine Standard scores
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Abstract Background Clinical classification of autistic patients based on current WHO criteria provides a valuable but simplified depiction of the true nature of the disorder. Our goal is to determine the biology of the disorder and the ASD-associated genes that lead to differences in the severity and variability of clinical features, which can enhance the ability to predict clinical outcomes. Method Novel Whole Exome Sequencing data from children ( n = 33) with ASD were collected along with extended cognitive and linguistic assessments. A machine learning methodology and a literature-based approach took into consideration known effects of genetic variation on the translated proteins, linking them with specific ASD clinical manifestations, namely non-verbal IQ, memory, attention and oral language deficits. Results Linear regression polygenic risk score results included the classification of severe and mild ASD samples with a 81.81% prediction accuracy. The literature-based approach revealed 14 genes present in all sub-phenotypes (independent of severity) and others which seem to impair individual ones, highlighting genetic profiles specific to mild and severe ASD, which concern non-verbal IQ, memory, attention and oral language skills. Conclusions These genes can potentially contribute toward a diagnostic gene-set for determining ASD severity. However, due to the limited number of patients in this study, our classification approach is mostly centered on the prediction and verification of these genes and does not hold a diagnostic nature per se. Substantial further experimentation is required to validate their role as diagnostic markers. The use of these genes as input for functional analysis highlights important biological processes and bridges the gap between genotype and phenotype in ASD.
ISSN:	1479-7364 1473-9542 1479-7364